Abstract
Nanoparticles of several organic and inorganic materials are nowadays under investigation for many diverse technologies. Amorphous silicon dioxide, also known as silica, is a versatile material for nanostructure preparation. Silica nanoparticles with different structure or surface chemistry have been prepared for biomedical applications. Size, shape and functionalization rule nanoparticle interaction with cells and tissues finally regulating the potential toxic effects. “Ad hoc” surface chemical moieties and specific physical features of their structure increase silica nanoparticle biocompatibility suggesting their possible future employment for gene or drug delivery.
Keywords: Nanoparticles, silica, drug delivery, biocompatibility, toxicity, nanomedicine
Drug Delivery Letters
Title: SiO2 NPs: Promising Candidates for Drug and Gene Delivery
Volume: 1 Issue: 1
Author(s): Giuseppe Bardi
Affiliation:
Keywords: Nanoparticles, silica, drug delivery, biocompatibility, toxicity, nanomedicine
Abstract: Nanoparticles of several organic and inorganic materials are nowadays under investigation for many diverse technologies. Amorphous silicon dioxide, also known as silica, is a versatile material for nanostructure preparation. Silica nanoparticles with different structure or surface chemistry have been prepared for biomedical applications. Size, shape and functionalization rule nanoparticle interaction with cells and tissues finally regulating the potential toxic effects. “Ad hoc” surface chemical moieties and specific physical features of their structure increase silica nanoparticle biocompatibility suggesting their possible future employment for gene or drug delivery.
Export Options
About this article
Cite this article as:
Bardi Giuseppe, SiO2 NPs: Promising Candidates for Drug and Gene Delivery, Drug Delivery Letters 2011; 1 (1) . https://dx.doi.org/10.2174/2210304x11101010009
DOI https://dx.doi.org/10.2174/2210304x11101010009 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ceramide-Based Therapeutics for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry Retinoid Related Molecules an Emerging Class of Apoptotic Agents with Promising Therapeutic Potential in Oncology: Pharmacological Activity and Mechanisms of Action
Current Pharmaceutical Design Recent Advances in the Discovery of GSK-3 Inhibitors from Synthetic Origin in the Treatment of Neurological Disorders
Current Drug Targets Ultrasound Assisted Synthesis of 2-alkynyl Pyrazolo[1,5-a]pyrimidines as Potential Anti-cancer Agents
Letters in Drug Design & Discovery Ion Channels as Important Targets for Antiepileptic Drug Design
Current Drug Targets P2X7 Receptors: Channels, Pores and More
CNS & Neurological Disorders - Drug Targets Boron Nitride Nanotubes: A Novel Vector for Targeted Magnetic Drug Delivery
Current Nanoscience Recent Therapeutic Advances for Treating Medulloblastoma: Focus on New Molecular Targets
CNS & Neurological Disorders - Drug Targets Recent Evidence of the Regulatory Role of PPARs in Neural Stem Cells and Their Underlying Mechanisms for Neuroprotective Effects
Current Stem Cell Research & Therapy MAP Kinase Pathways in Neuronal Cell Death
CNS & Neurological Disorders - Drug Targets Overview of the Formulations and Analogs in the Taxanes' Story
Current Medicinal Chemistry The Role of Melatonin in Multiple Sclerosis, Huntington's Disease and Cerebral Ischemia
CNS & Neurological Disorders - Drug Targets Promising Targets in Anti-cancer Drug Development: Recent Updates
Current Medicinal Chemistry Epigenetic Interventions Increase the Radiation Sensitivity of Cancer Cells
Current Pharmaceutical Design Butyrate and Colorectal Cancer: The Role of Butyrate Transport
Current Drug Metabolism Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 Alpha: An Emerging Target for Neuroprotection in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Copper and Heme-Mediated Abeta Toxicity: Redox Chemistry, Abeta Oxidations and Anti-ROS Compounds
Current Topics in Medicinal Chemistry Pleiotropic, Cardioprotective Effects of Omega-3 Polyunsaturated Fatty Acids
Mini-Reviews in Medicinal Chemistry MDM2 Increases Drug Resistance in Cancer Cells by Inducing EMT Independent of p53
Current Medicinal Chemistry Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses
Current Pharmaceutical Biotechnology